Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project
Prognosevorhersage und gemeinsame Entscheidungsfindung für personalisierte Antikoagulation nach unprovozierter venöser Thromboembolie: das MORPHEUS-Projekt
Thrombosis and Haemostasis · 28.07.2026
DOI: 10.1055/a-2913-2857 ↗Auf einen Blick
Das internationale MORPHEUS-Projekt entwickelt und validiert zeitabhängige Risikoskalen für Patient:innen mit unprovozierter VTE. Die klinische Wirksamkeit soll in einer 2.400 Patient:innen umfassenden Studie geprüft werden.
Fragestellung
Entwicklung und Validierung zeitabhängiger, multikomponentiger Risikovorhersagen und sozial-anthropologischer Skalen zur Optimierung der Langzeit-Antikoagulation nach unprovozierter VTE.
Methode
Internationales, multidisziplinäres Forschungsprogramm in 8 europäischen Ländern; Kombination klinischer, biologischer, Bildgebungs- und pharmakologischer Biomarker mit sozial-anthropologischen Skalen; Evaluation in einer stepped-wedge cluster randomisierten Studie.
Ergebnisse
Die TDMI sollen die individualisierte Risikostratifizierung verbessern. Erwartet werden weniger unnötige verlängerte Antikoagulation, weniger Blutungskomplikationen sowie bessere Patient:innenzufriedenheit, Adhärenz und Lebensqualität.
Schlussfolgerung der Autor:innen
Das MORPHEUS-Projekt soll personalisierte Antikoagulationsentscheidungen unterstützen und die Langzeitergebnisse nach unprovozierter VTE verbessern.
Kernaussagen
- TDMI für Rezidiv- und Blutungsrisiko nach unprovozierter VTE
- Einbezug von Patient:innenperspektiven und Shared Decision-Making
- Wirksamkeit in einer stepped-wedge cluster randomisierten Studie geplant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Klinische Studie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 28.07.2026. Verfasst von Francis Couturaud und 38 weiteren Autor:innen. Beteiligte Einrichtung: Brest University Hospital Centre, Department of Internal Medicine and Chest Diseases, Bretagne, France, Brest. Gefördert von: HORIZON EUROPE.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
In patients with unprovoked venous thromboembolism (VTE), indefinite anticoagulation is recommended to prevent recurrence but may expose some patients to unnecessary long-term bleeding risk. Current clinical scores and biomarkers have limited discriminative performance, do not capture the time-dependent nature of VTE, and do not incorporate patients' perspectives or support shared decision-making.
Objectives
To develop and validate time-dependent, multicomponent risk prediction scores and socio-anthropological scales (TDMI) integrated in a shared decision-making process to optimize long-term anticoagulation management after unprovoked VTE.
Methods
MORPHEUS is an international, multidisciplinary research programme conducted in eight European countries. The TDMI will combine clinical, biological, imaging, and pharmacological biomarkers with socio-anthropological scales reflecting patients' lived experiences, preferences, and perceptions of risk. Candidate components will be identified through systematic literature review, Delphi consensus, qualitative interviews with patients and physicians, and pooled analyses of large prospective European VTE cohorts including clinical outcomes, biobanks, and imaging data. Dynamic, multi-level, time-dependent prediction models for recurrent VTE and anticoagulant-related bleeding will be derived using advanced statistical and machine-learning approaches. The clinical effectiveness and acceptability of TDMI integrated in a shared decision-making process will be evaluated in a stepped-wedge cluster randomized trial enrolling 2,400 patients with a first unprovoked VTE.
Results
The TDMI is expected to improve individualized risk stratification, reduce unnecessary extended anticoagulation, lower bleeding complications, and improve patient satisfaction, treatment adherence, and quality of life.
Conclusion
The MORPHEUS project will support personalized anticoagulation decisions and improve long-term outcomes in patients after unprovoked VTE.
Autor:innen und Institutionen
- Brest University Hospital Centre, Department of Internal Medicine and Chest Diseases, Bretagne, France, Brest.
- INSERM U1304 GETBO (Groupe d'Étude de la Thrombose de Bretagne Occidentale), Univ Brest, Bretagne, France, Brest.
- Ramón y Cajal Hospital, IRYCIS and Alcalá de Henares University, Department of Medicine, Madrid, Spain, Madrid.
- Université Paris Descartes, Sorbonne Paris Cité, and INSERM UMR S 1140, France, France, Paris.
- Institute of Public Goods and Policies, Consejo Superior de Investigaciones Científicas Instituto de Ciencias Agrarias, Community of Madrid, Spain, Madrid.
- KTH Royal Institute of Technology, Department of Protein Science, Sweden, Stockholm.
ORCID-Profile: David Jiménez, Frederikus A Klok, Stavros V Konstantinides
Förderung
- HORIZON EUROPE
Zitieren
APA
Couturaud, F., Jiménez, D., Sanchez, O., Turrini, M., Odeberg, J., Klok, F. A., Presles, E., Bourgain, C., Konstantinides, S. V., Huisman, M. V., Morange, P. E., Germain, M., Svendsen, M. N., Ollier, E., Tromeur, C., Salaun, P. Y., Tregouet, D. A., Yaiche, S., Bresson Ladegaard Knox, J., …, & Lemarié, C. (2026). Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2913-2857
Vancouver
Couturaud F, Jiménez D, Sanchez O, Turrini M, Odeberg J, Klok FA, et al. Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2913-2857
BibTeX
@article{Couturaud2026,
author = {Couturaud, Francis and Jiménez, David and Sanchez, Olivier and Turrini, Mauro and Odeberg, Jacob and Klok, Frederikus A and Presles, Emilie and Bourgain, Catherine and Konstantinides, Stavros V and Huisman, Menno V and Morange, Pierre Emmanuel and Germain, Marine and Svendsen, Mette N and Ollier, Edouard and Tromeur, Cecile and Salaun, Pierre-Yves and Tregouet, David Alexandre and Yaiche, Sarhan and Bresson Ladegaard Knox, Jeanette and Munsch, Gaëlle and Fortin-Prunier, Hélène and Righini, Marc and Pruszczyk, Piotr and Schreiber, Karen and Patteri, Tijana and Van de Merwe, Lisa and Camilleri, Eleonora and Eikenboom, Anna and Becker, Dorothea and Martin, Nadine and Dissaux, Brieg and Bourhis, David and Bertoletti, Laurent and Fischer, Susanne and Murano, Maria Cristina and Hartlev, Mette and Hurst, Samia and Laporte, Silvy and Lemarié, Catherine},
title = {Prognosis Prediction and Shared Decision-Making for Personalized Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS Project},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2913-2857}
}
EUVIMED